That booty
means business

Butt First, change the way you treat cellulite with Qwo®

QWO is the first and only FDA-approved injectable treatment for moderate to severe cellulite in the buttocks of adult women.

Get to know QWO
Clinical Education Center
actor portrayal
Actor portrayal

Before & after results

Age: 48
FST: III
BMI: 17.9
Age: 52
FST: II
BMI: 23.6
Age: 47
FST: II
BMI: 22.0

Slideshow Items

FST = Fitzpatrick skin type   BMI = Body mass index

Primary Efficacy Endpoint: Two-grade or better improvement measured by both physician and patient rated photonumeric cellulite severity score assessments occurred in 7.6% (P=.006) of patients.1 Phase 3 subject images. Individual results may vary. After images were taken after third treatment with QWO.

Primary Efficacy Endpoint: Two-grade or better improvement measured by both physician and patient rated photonumeric cellulite severity score assessments occurred in 7.6% (P=.006) of patients.1 Phase 3 subject images. Individual results may vary. After images were taken after third treatment with QWO.

Actual patient. Photos courtesy of China Battista, APN-BC. Photos are unretouched. Individual results may vary. After images were taken after third treatment with QWO.

The Opportunity for
Your Practice

The QWO difference:

Studied in more than 1,800 patients, QWO is the most clinically studied FDA-approved treatment for cellulite available.2

Visible results 28 days after the third treatment (21 days apart).1,3*

*In clinical trials, efficacy was assessed at Day 71.
Individual results may vary.

In the clinical trials, no post-treatment downtime was required.4

As seen on

Shape logo.
NEWBEAUTY logo.
ELLE logo.
Bloomberg logo.
MedScape logo.

“I am thrilled there is now an FDA-approved injectable treatment option for cellulite.”

– Anne Chapas, MD

Adult woman’s buttock with arrows pointing to variations of acceptable laxity Adult woman’s buttock with arrows pointing to variations of acceptable laxity

Perceived Mechanism of Action

The exact mechanism for the treatment of moderate to severe cellulite is unknown.3

Learn More

Clinical Education Center

Here you will find additional information and resources.

Want to learn more about QWO?

Head over to the Clinical Education Center for more information.

Clinical Education Center
Learn More

Indication

Qwo® is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women.

Important Safety Information for QWO

Contraindications

QWO is contraindicated in patients with a history of hypersensitivity to collagenase or to any of the excipients or the presence of infection at the injection sites.

Warnings and Precautions

Hypersensitivity Reactions

Serious hypersensitivity reactions including anaphylaxis have been reported with the use of collagenase clostridium histolyticum. If such a reaction occurs, further injection of QWO should be discontinued and appropriate medical therapy immediately instituted. Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions.

Injection Site Bruising

In clinical trials, 84% of subjects treated with QWO experienced injection site bruising. Subjects with coagulation disorders or using anticoagulant or antiplatelet medications (except those taking ≤150 mg aspirin daily) were excluded from participating in Trials 1 and 2.

QWO should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet (except those taking ≤150 mg aspirin daily) or anticoagulant therapy.

Substitution of Collagenase Products

QWO must not be substituted with other injectable collagenase products.

QWO is not intended for the treatment of Peyronie’s Disease or Dupuytren’s Contracture.

Adverse Reactions

In clinical trials, the most commonly reported adverse reactions in patients treated with QWO with an incidence ≥ 10% were at the injection site: bruising, pain, nodule and pruritus.

View Full Prescribing Information for QWO.